Oncogene Contents: Volume 41 Number 9

In this Issue: Review Article Article Brief Communications Correction

Oncogene Contents: Volume 41 Issue 9

Review Article

Neurofibromin and suppression of tumorigenesis: beyond the GAP Juan Mo, Stefanie L. Moye, Renee M. McKay & Lu Q. Le Review Article | 23 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02156-y

The proprotein convertase furin in cancer: more than an oncogene Zongsheng He, Abdel-Majid Khatib & John W. M. Creemers Review Article | 07 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02175-9

Article

SELENOF is a new tumor suppressor in breast cancer Alexandra Zigrossi , Lenny K. Hong , Roudy C. Ekyalongo , Cindy Cruz-Alvarez , Emily Gornick et al. Article | 27 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02158-w

A dysbiotic microbiome promotes head and neck squamous cell carcinoma Daniel N. Frank , Yue Qiu , Yu Cao , Shuguang Zhang , Ling Lu et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02137-1

The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation Yangfan Xu , Xiaoyu He , Shanzheng Wang , Baofa Sun , Ruobing Jia et al. Article | 03 February 2022 Oncogene 41 | doi:10.1038/s41388-021-02146-0

Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1 Hui Li , Mridul Roy , Long Liang , Wenjie Cao , Bin Hu et al. Article | 07 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02167-9

Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130 Oh-Joon Kwon , Boyu Zhang , Deyong Jia , Li Zhang , Xing Wei et al. Article | 08 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02169-7

Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells Elena Madrazo , Raquel González-Novo , Cándido Ortiz-Placín , Mario García de Lacoba , África González-Murillo et al. Article | 08 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02168-8

Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy Anthony DiNatale , Ramanpreet Kaur , Chen Qian , Jieyi Zhang , Michael Marchioli et al. Article | 08 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02174-w

Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma Joo-Yun Byun , Kun Huang , Jong Suk Lee , Wenjie Huang , Li Hu et al. Article | 10 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02166-w

Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment Klaire Yixin Fjæstad , Anne Mette Askehøj Rømer , Victor Goitea , Astrid Zedlitz Johansen , Marie-Louise Thorseth et al. Article | 11 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02170-0

Brief Communications

The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner Anna-Lena Meinhardt , Enkhtsetseg Munkhbaatar , Ulrike Höckendorf , Michelle Dietzen , Marta Dechant et al. Brief Communication | 29 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02161-1

Correction

Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor Yan Liu , Marie V. Nelson , Christopher Bailey , Peng Zhang , Pan Zheng et al. Correction | 19 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02042-7

Correction to: Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling Shangce Du , Zhi Yang , Xiaofeng Lu , Suhail Yousuf , Min Zhao et al. Correction | 19 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02096-7

Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome Francesco Rugolo , Nicolas G. Bazan , Jorgelina Calandria , Bokkyoo Jun , Giuseppe Raschellà et al. Correction | 20 January 2022 Oncogene 41 | doi:10.1038/s41388-021-02164-y

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Oncogene.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.